Keyword: Cancer Drugs Fund
News
30.10.2015
- In what is being called a “landmark clinical trial” of genetic oncology, UK researchers have discovered that AstraZeneca’s Lynparza (olaparib), approved in 2015 to treat ovarian...
News
10.09.2015
- UK drug cost-effectiveness agency National Institute for Health and Care Excellence, NICE, has approved the use of US drugmaker Merck’s Keytruda for treatment of certain cases of...
